focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

3 Apr 2020 07:00

RNS Number : 6598I
Zoetic International PLC
03 April 2020
 

 

3 April 2020

 

Zoetic International plc

("Zoetic" or the "Company")

 

Issue of equity

 

Zoetic, the London listed vertically integrated CBD company, announces the issue of 12,900,000 new ordinary shares of 1 pence each in the capital of the Company to members of its management team in accordance with incentive arrangements established in March 2019.

 

The Company announced its move into CBD on 19 March 2019 and, as part of those plans, also announced on that date that it would enter into an agreement to lease an indoor growing facility. At the same time, the Company entered into arrangements with the management team that had previously operated that facility, bringing with them all the skills and abilities for Zoetic to commence operations immediately. To incentivise the management team, the Company agreed to issue them with 5,000,000 warrants (which were exercised and placed with investors in June 2019) and a further 12,900,000 ordinary shares 12 months' after commencement of operations.

 

The 12,900,000 ordinary shares have accordingly now been issued as fully paid in equal amounts to Trevor Taylor, the Company's Chief Strategy Officer, and Antonio Russo, the Company's Chief Revenue Officer.

 

Application will be made for an additional 12,900,000 ordinary shares in the Company (the "New Ordinary Shares") to be admitted to trading on the Official List of the UK Listing Authority by way of a Standard Listing and to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). Admission is expected to take place on 9 April 2020.

 

Following Admission, the New Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue, including the right to receive all dividends and other distributions declared, and the total number of ordinary shares with voting rights will be 185,820,034. This figure may be used by Zoetic shareholders as the denominator for calculations to determine if they have a notifiable interest in Zoetic under the Disclosure and Transparency Rules, or if such interest has changed.

 

Following Admission, Ox Distributing, LLC and the Schrader family's holding of 24,750,000 ordinary shares will represent 13.32% of the Company's total voting rights and Trevor Taylor and Antonio Russo's holding of 6,450,000 ordinary shares each will represent 3.47% of the Company's total voting rights.

 

Commenting, Trevor Taylor and Antonio Russo said: "We are delighted to become significant long term shareholders in Zoetic and we look forward to continuing to build a successful business along with other members of the management team."

 

**ENDS**

 

Enquiries

 

Zoetic International plc +44 (0) 1738 472 029

Nick Tulloch

 

Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656

Nick Harriss

Nick Naylor

 

IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEVLLFBBZLLBBK
Date   Source Headline
25th Jun 20204:00 pmRNSHolding(s) in Company
24th Jun 20203:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSSubscription for Equity
1st Jun 20207:00 amRNSNew Distribution Agreement and Trading Update
29th May 20207:00 amRNSFiling of Patents
27th May 20207:00 amRNSSale of DTU Interest and Kansas Nitrogen Assets
15th May 20207:00 amRNSTrading Update
11th May 20203:36 pmRNSHolding(s) in Company
6th May 20202:34 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSBoard and Strategy Changes, and Trading Update
3rd Apr 20207:00 amRNSIssue of Equity
1st Apr 20207:00 amRNSCOVID-19 Update
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSIssue of Equity
20th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20207:00 amRNSOperational update
12th Feb 20207:00 amRNSSubscription to raise £0.39 million
5th Feb 20207:00 amRNSTrading Update
23rd Dec 20197:00 amRNSInterim Results
16th Dec 20197:00 amRNSSettlement of Diversion Debt & Notice of Results
28th Nov 20197:00 amRNSResult of General Meeting
25th Nov 20197:00 amRNSTrading Update
14th Nov 20199:19 amRNSIssue of Equity
13th Nov 20192:06 pmRNSSecond Price Monitoring Extn
13th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSListing on the OTC
8th Nov 20199:01 amRNSIssue of Equity
7th Nov 20197:00 amRNSNotice of General Meeting
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
29th Oct 20194:42 pmRNSSecond Price Monitoring Extn
29th Oct 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20197:00 amRNSIssue of Shares
18th Oct 201911:05 amRNSSecond Price Monitoring Extn
18th Oct 201911:00 amRNSPrice Monitoring Extension
8th Oct 20197:00 amRNSAdoption of new share option scheme
4th Oct 20197:00 amRNSTrading Update
17th Sep 20197:00 amRNSDirectorate Change
12th Sep 201912:30 pmRNSDirector/PDMR Shareholding
9th Sep 201911:15 amRNSChange of Name
6th Sep 201910:30 amRNSDirector/PDMR Shareholding
4th Sep 201911:05 amRNSSecond Price Monitoring Extn
4th Sep 201911:00 amRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSDirectorate Change
30th Aug 20194:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.